- Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study2008 | Second Faculty of Medicine
- Microsatellite Polymorphism in Haem Oxygenase 1 Gene Promoter in Multiple Sclerosis2012 | First Faculty of Medicine
- Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis2000 | Central Library of Charles University